H. Scheijgrond

440 total citations
11 papers, 318 citations indexed

About

H. Scheijgrond is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, H. Scheijgrond has authored 11 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in H. Scheijgrond's work include Cardiac, Anesthesia and Surgical Outcomes (3 papers), Nail Diseases and Treatments (3 papers) and Blood Pressure and Hypertension Studies (2 papers). H. Scheijgrond is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (3 papers), Nail Diseases and Treatments (3 papers) and Blood Pressure and Hypertension Studies (2 papers). H. Scheijgrond collaborates with scholars based in Belgium, Netherlands and Switzerland. H. Scheijgrond's co-authors include J Brugmans, J. Van Cutsem, J. Heykants, J.W.M. van der Meer, J.J. Keuning, J. Symoens, V. Schuermans, Robert S. Reneman, E.C. HUSKISSON and Robert J. Kahn and has published in prestigious journals such as Clinical Infectious Diseases, Annals of the Rheumatic Diseases and Anesthesia & Analgesia.

In The Last Decade

H. Scheijgrond

11 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Scheijgrond Belgium	7	112	110	36	36	35	11	318
Lois Jessen United States	6	117 1.0×	150 1.4×	32 0.9×	15 0.4×	36 1.0×	7	308
Alan E. Hassell United States	8	140 1.3×	173 1.6×	33 0.9×	13 0.4×	46 1.3×	11	375
Gilbert R. Park United Kingdom	5	92 0.8×	107 1.0×	33 0.9×	11 0.3×	39 1.1×	12	301
Robert Birchall United States	9	56 0.5×	70 0.6×	87 2.4×	32 0.9×	26 0.7×	24	459
Heike Oberwittler Germany	8	89 0.8×	139 1.3×	42 1.2×	19 0.5×	82 2.3×	10	357
M Breteau France	12	72 0.6×	54 0.5×	35 1.0×	9 0.3×	90 2.6×	42	405
Dennis H. Giesing United States	11	110 1.0×	113 1.0×	74 2.1×	20 0.6×	52 1.5×	18	479
S. Copeland United Kingdom	8	68 0.6×	27 0.2×	34 0.9×	20 0.6×	24 0.7×	11	347
H M Siefert Germany	13	73 0.7×	50 0.5×	34 0.9×	20 0.6×	167 4.8×	22	411
Malcolm D. Eve United Kingdom	8	105 0.9×	168 1.5×	10 0.3×	18 0.5×	79 2.3×	8	500

Countries citing papers authored by H. Scheijgrond

Since Specialization

Citations

This map shows the geographic impact of H. Scheijgrond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Scheijgrond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Scheijgrond more than expected).

Fields of papers citing papers by H. Scheijgrond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Scheijgrond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Scheijgrond. The network helps show where H. Scheijgrond may publish in the future.

Co-authorship network of co-authors of H. Scheijgrond

This figure shows the co-authorship network connecting the top 25 collaborators of H. Scheijgrond. A scholar is included among the top collaborators of H. Scheijgrond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Scheijgrond. H. Scheijgrond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Goldstein, M, Jean‐Louis Vincent, Luc Barvais, et al.. (1993). Administration of Nebivolol After Coronary Artery Bypass in Patients with Altered Left Ventricular Function. Journal of Cardiovascular Pharmacology. 22(2). 253–258. 17 indexed citations

Reneman, Robert S., et al.. (1989). Ketanserin in the Treatment of Systemic Hypertension During and Following Coronary Artery Bypass Surgery. Angiology. 40(11). 1001–1010. 4 indexed citations

Scheijgrond, H., et al.. (1987). Multicenter Study with Ketanserin in Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S135–S137. 2 indexed citations

Scheijgrond, H., et al.. (1983). The Use of Ketanserin, a 5-Hydroxytryptamine Receptor Antagonist, for Treatment of Postoperative Hypertension Following Coronary Artery Bypass Surgery. Anesthesia & Analgesia. 62(1). 63???69–63???69. 27 indexed citations

Veys, E M, E.C. HUSKISSON, M. Rosenthal, et al.. (1982). Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Annals of the Rheumatic Diseases. 41(5). 441–443. 19 indexed citations

Brugmans, J, et al.. (1980). [Oral long-term treatment of onychomycoses with ketoconazole (author's transl)].. PubMed. 23(8). 405–15. 5 indexed citations

Symoens, J., et al.. (1980). An Evaluation of Two Years of Clinical Experience with Ketoconazole. Clinical Infectious Diseases. 2(4). 674–691. 108 indexed citations

Meer, J.W.M. van der, J.J. Keuning, H. Scheijgrond, et al.. (1980). The influence of gastric acidity on the bio-availability of ketoconazole. Journal of Antimicrobial Chemotherapy. 6(4). 552–554. 119 indexed citations

Brugmans, J, et al.. (1980). Orale Langzeitbehandlung von Onychomykosen mit Ketoconazol. Mycoses. 23(8). 405–415. 6 indexed citations

10.

Scheijgrond, H., et al.. (1978). Multinational evaluation of etomidate for anesthesia induction. Conclusions and consequences.. PubMed. 27(2). 52–9. 7 indexed citations

11.

Scheijgrond, H., et al.. (1976). Anaesthesia with sulfentanil-analgesia in carotid and vertebral arteriography. A comparison with fentanyl.. PubMed. 25(8). 380–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact